Milford, PA -- (ReleaseWire) -- 12/12/2016 -- Ken Manzo, the founder of Manzo Pharmaceuticals, LLC., (OTC:MNZO) is pleased to announce the launch of a new and unique patented probiotic, "Lacto-Freedom Probiotic". It stays in the intestines and aids in the digestion of lactose containing foods, designed specifically for people who do not properly digest lactose in dairy products. Lacto-Freedom™ probiotic prevents abdominal pain, gas, abdominal bloating, diarrhea, and nausea that may result from lactose sensitivity. It is taken for only 7 days and the lactose digesting effects last for months.

Lactose sensitivity is the inability to properly digest lactose, a sugar found in milk and milk products. Lactose sensitivity is caused by a deficiency of lactase, the enzyme which is produced by the cells lining the small intestine. Lactase breaks down lactose into two simpler forms of sugar which are then absorbed into the bloodstream. Common foods that are high in lactose include dairy products such as milk, cheese, and ice cream. Lactose is also added to some foods, such as bread and baked goods, cereals, and snacks. People with lactose sensitivity often experience abdominal pain, gas, bloating, diarrhea, and nausea after consuming lactose containing foods. These issues range from mild to severe, based on the amount of lactose consumed and the amount a person can tolerate. Experts believe lactose sensitivity affects up to 75% of the world's adult population.

The intestinal lining is made up of billions of bacteria, both good and bad. Probiotics are supplements which contain "good" bacteria and when consumed add beneficial bacteria to the intestines. Manzo Pharmaceuticals developed a probiotic that stays in the intestines, produces lactase, and allows the body to more efficiently digest lactose for months, so you can enjoy dairy without the discomfort.

Lacto-Freedom Probiotic:
-Aids in the digestion of lactose containing foods.
-Taken for only 7 days and effect last for months.
-Patented, clinically tested.
-More convenient and more economical than taking lactase tablets.

Available at www.LactoFreedom.com

Lacto-Freedom Probiotic stays in the intestines and produces lactase and eliminates or greatly reduces the issues associated with lactose sensitivity so the person can enjoy dairy without the discomfort..

Watch This Brief Video On How Lacto-Freedom Works In The Intestines

Lacto-Freedom is Available at www.LactoFreedom.com and at Amazon.com. Lacto-Freedom has received an amazing rating of 5.0 out of 5 Stars on Amazon.

Here is what some people have said about it:

Alex M: "I can't thank you enough for inventing this product and sharing it with me... It's literally changed my life. And apparently, it keeps changing my life months and months and months after dosing. I wonder if the time will eventually come when I need to redose, which I suspect will be after a bout of gastroenteritis or course of antibiotics or something of that nature. But it seems like the regimen is pretty robust."..."This product is why I can eat ice cream again."

Allan W: "I was part of the clinical. It worked great. I took it for a week, had to wait another week and then was great for about 2-1/2 months. I just got my second bottle a few weeks ago and I'm back on track. It's funny, I still get so nervous when I eat dairy. Reality hasn't set in yet. Love this product"

Jessica S "I was a little skeptical since I have always been severely affected by any dairy products with bad cramps, diarrhea etc.This product has been life changing for me. I received a sample a few months ago and took it for the 7 days. I was a little skeptical since I have always been severely affected by any dairy products with bad cramps, diarrhea etc. Since taking Lacto-Freedom, I now have been symptom free for well over two months now and have been eating and drinking all the dairy products I want."

Currently, people with lactose sensitivity are limited to two mediocre options for managing their lactose sensitivity. Their limited options include avoiding lactose-containing foods and the other is taking lactase supplements at the start of every single lactose containing meal.

For more information and to purchase, visit: www.LactoFreedom.com

Follow Us On Facebook.com/manzopharma

DISCLAIMER: This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

Source: UPTICK Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/lacto-freedom-probiotic-for-people-who-are-sensitive-to-lactose-750512.htm

Milford, PA -- (ReleaseWire) -- 08/01/2016 -- Manzo Pharmaceuticals, Inc. (OTCPink:MNZO) announced today that the company's President, Kenneth Manzo, has received a verbal Wells Notice from the US Securities and Exchange Commission.

The notice addresses two press release issues, Mr. Manzo's accepting and selling unregistered securities in another company prior to his becoming MNZO's CEO, and certain sales of unregistered securities by others. Mr. Manzo himself has never sold any MNZO stock.

A Wells Notice is neither a formal allegation of wrongdoing nor a finding that there was any violation of law. Rather, it provides an opportunity to respond to issues raised by the SEC staff and offer perspective prior to any SEC decision.

The matters at issue concern Mr. Manzo directly. Mr. Manzo is negotiating a settlement with the SEC in these matters. Mr Manzo intends to continue to cooperate fully with the SEC. The Company and Mr. Manzo will have no further comment on this matter until it is fully resolved.

About Manzo Pharmaceuticals, Inc.
Manzo Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, and testing of patented and non-patented solutions and remedies. Most notable is a patented probiotic for lactose intolerance, and a natural sleep aid.

For more information follow the company on twitter at @manzopharma, and visit http://www.manzopharma.com.

DISCLAIMER:
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

For more information on this press release visit: http://www.releasewire.com/press-releases/manzo-pharmaceuticals-inc-announced-today-that-the-companys-president-kenneth-manzo-has-received-a-verbal-wells-notice-from-the-us-securities-and-exchange-commission-710667.htm

Milford, PA -- (ReleaseWire) -- 05/16/2016 -- Providing a natural and non habit forming solution for people to aid their sleep, Manzo Pharmaceuticals' SOMNAID is getting consistent five star reviews from customers. Manufactured in USA under strict GMP quality control guidelines, these pills have no side effects.

Taking sleeping pills for a sound sleep is not a new thing in this fast paced and hectic lifestyle for people. But the issue is that most of the over-the-counter sleeping pills are prone to get habitual of. People get addicted to them and they also end up with side effects like dizziness, constipation, confusions and troubles in urinating. After thorough research and work, Manzo Pharmaceuticals had come up with a completely natural and non habit forming way of sleep aid in the form of their new product – Somnaid, which has been getting top customer reviews and ratings on Amazon.

Reportedly, Somnaid sleeping pills are made up from Melatonin, 5 – Hydroxytryptophan and L – Theanine. Now melatonin is the most popular natural aid for sleep. "Using melatonin as a supplement has proven some impressive results in aiding sleep without troubles or side effects", the company officials said. Further, 5 – HTP is again an important initiator of sleep as it turns into serotonin in brain. L – Theanine is effective in reducing stress levels and improving quality of sleep.

"We have used the right quantities of all these three natural and effective sleeping aids to come up with the best possible product for people to get quality sleep without forming any habit or facing any side effects. We are glad that people have welcomed our product and given us such support", the company officials informed.

It was reported further that the manufacturing of this product is being carried out in USA under strict GMP quality control guidelines and in accordance with US Food and Drug administration policies. "We do not compromise with the quality aspect of our products at any stage", company representative informed.

The company experts have advised a dosage of 1-2 tablets 30-45 minutes before sleeping. Created after years' long hard work and research, Somnaid is now getting the applauds for the effective results and no side-effects.

For more information, one can visit their official website at: http://www.somnaid.com/

DISCLAIMER: This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

For more information on this press release visit: http://www.releasewire.com/press-releases/manzo-pharmaceuticals-receives-top-customer-ratings-for-their-safe-and-non-habit-forming-natural-sleep-aid-689314.htm

Milford, PA -- (ReleaseWire) -- 05/05/2016 -- CEO of Manzo Pharmaceuticals (OTCPink:MNZO) and creator of patented Lacto-Freedom probiotic, Kenneth Manzo, recently visited their manufacturer's GMP and FDA approved probiotic plant in the USA and expressed his great satisfaction with the manufacturer and their professionalism.

Shortly after the confirmation of the deal between Manzo Pharmaceuticals and their new manufacturing partners, Ken Manzo – CEO Manzo Pharmaceuticals - visited the plant and took a detailed tour to understand the working processes and the facilities available. Afterwards, he expressed his immense satisfaction with the plant and the professionalism shown by people there.

"I was very impressed and pleased with their manufacturing plant and professionalism. They are a major USA based probiotic producer and supplier, and their professionalism and facilities prove why that is so. I am glad we are working together on this deal", said Ken Manzo.

Reportedly, samples of their Lacto-Freedom probiotic were sent to the manufacturing facility to test and produce. Working on the samples received, the manufacturers have already started testing and reproducing it so they are one step closer to making it available on the market.

"The manufacturers have made sure that they come up with the testing and production at the highest possible level and thereby making sure that the end product is the best which people can get", the CEO stated.

The visit of the manufacturing facility by Ken Manzo showed his concern and active participation in the whole process, starting from creating this unique and revolutionary probiotic, getting it patented, finalizing a deal with one of the major manufacturers of probiotics and is now producing the probiotic. With the probiotic under production, people with Lactose Intolerance will not have to wait very long to have lactose containing products without discomfort.

About Manzo Pharmaceuticals, Inc.
Manzo Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, and testing of patented and non-patented solutions and remedies. Most notable is a patented probiotic for lactose intolerance, and a natural sleep aid.

For more information follow the company on twitter at @manzopharma, and visit www.manzopharma.com.

DISCLAIMER:
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

Contact:
Manzo Pharmaceuticals Inc.
570-249-6000
manzopharma@outlook.com

Source: UPTICK Newswire

For more information on this press release visit: http://www.releasewire.com/press-releases/kenneth-manzo-ceo-manzo-pharmaceuticals-visited-the-probiotic-manufacturing-plant-and-was-impressed-with-the-manufacturer-and-production-has-commenced-686879.htm